Miracle Breakthrough: Aussie Baby Beats Rare Epilepsy with Groundbreaking Treatment That Could Change the Face of Paediatric Care Forever
- Aussie baby Bohdi becomes the first in the world to receive a revolutionary new treatment for a rare and often-fatal form of epilepsy
- The eight-month-old’s seizures stopped within days of starting the medication, and he’s now smiling again after months of around-the-clock care
- The NSW Government’s Innovative Therapies Pathway is paving the way for personalised treatment for kids with ultra-rare diseases, and experts say it could become a global model for paediatric care
- The breakthrough treatment has given hope to families who thought they had run out of options, and could change the lives of countless kids suffering from rare conditions
For eight-month-old Bohdi, life was a never-ending cycle of seizures and hospital visits.
Born with KCNT1-related catastrophic epilepsy, a rare and often-fatal condition that causes up to 60 seizures a day, his parents thought they’d run out of options.
But thanks to a groundbreaking new treatment, Bohdi’s seizures have stopped, and he’s finally smiling again.
The treatment, made possible by the NSW Government’s Innovative Therapies Pathway, is the result of tireless work by paediatric neurologist Dr Kavitha Kothur, who discovered a medication that had only been trialed in adults.
By using “precision medication” to target the genetic cause of the condition, Dr Kothur and her team were able to stop the overactive brain currents that triggered Bohdi’s seizures.
Within days of starting the new medication, Bohdi’s seizures stopped, and for the first time in months, he no longer required around-the-clock care. His mother, Stephanie Higginson, says she’ll “never be able to thank Dr Kothur enough for what she’s done for my family”.
“She never gave up looking for answers, and she gave us hope when we needed it most. Her work changed our lives.
Bohdi’s now like a completely different baby.”
But Bohdi’s story is just the beginning.
The Innovative Therapies Pathway is paving the way for personalised treatment for kids with ultra-rare diseases, and experts say it could become a global model for paediatric care.
“We are entering a new era where highly personalised therapies for ultra-rare diseases are increasingly possible,” says Dr Michelle Lorentzos, Medical Lead for Advanced Therapeutics at Sydney Children’s Hospitals Network.
Analysis: What This Means for Australia
This breakthrough treatment has significant implications for Australia’s medical research system and the way we approach paediatric care.
As NSW Minister for Medical Research David Harris notes, “We are reaching an incredible point with precision medicine, where treatments can be tailored to the individual genetic causes of disease, offering hope to families who have previously had very limited options when it comes to treatment.”
The potential for this treatment to change the lives of countless kids suffering from rare conditions is enormous.
According to experts, the Innovative Therapies Pathway has the potential to become a global model for paediatric rare disease care, and could pave the way for new treatments for a range of conditions.
As Dr Lorentzos says, “This goes beyond a single medication or a single patient; it’s about a new way of delivering innovative treatments to children.”
Security analysts say that this breakthrough highlights the importance of investing in medical research and innovation, particularly in the field of paediatric care.
By supporting initiatives like the Innovative Therapies Pathway, Australia can continue to lead the way in developing new treatments and improving the lives of kids with rare conditions.
As for Bohdi and his family, they’re just grateful for a second chance at life.
“Bohdi’s breakthrough treatment highlights the strength of NSW’s medical research system and the impact on people’s lives when discoveries are translated rapidly and responsibly into patient care,” says Minister Harris.
“It can be truly life-changing.”
